PPTA PERPETUA RESOURCES CORP. Insider Trading

PPTA CFO Margaret Lyon Mckinsey sold 43,722 shares ($1.2M) at $27.57 avg, reducing stake 23.1%

Margaret Lyon Mckinsey executed 2 separate sales totaling 43,722 shares for $1,205,601.96 at a blended average price of $27.57 on February 12, 2026, reducing her holdings from 189,468 shares to 145,746 shares—a 23.1% reduction in position. The company is currently unprofitable with net income of $-25,756,120.00 over its most recent full fiscal year, and the stock has declined 12.9% over the past 30 days and 19.7% from its 52-week high of $34.96, though it has gained 17.5% over 90 days. The substantial reduction in an insider's stake at a company experiencing negative earnings warrants attention to whether this signals capital reallocation or other strategic considerations.

Paulson & Co. Inc. purchases 7,575,757 shares of PPTA for $100.0M at $13.20, raising stake to 32,347,299 shares (+30.6%)

Paulson & Co. Inc. deployed $99,999,992.40 ($100.0M) to acquire 7,575,757 shares at $13.20, a significant position increase of 30.6% from 24,771,542 to 32,347,299 shares. The transaction occurred when the stock was trading 25.2% below its 52-week high of $17.37, and despite the purchase price, the current market price of $13.00 suggests the purchase price has not yet been validated by the market. Perpetua Resources is unprofitable with net income of $-8,204,603.00 over its most recent full fiscal year, making this a substantial capital commitment to a loss-making enterprise. Paulson's cross-ticker track record shows mixed prior outcomes (50% 90-day win rate), and this purchase warrants monitoring to determine whether the subsequent price trajectory supports the insider's confidence in the opportunity.

Director Haddock Richie Darrin bought 5,780 shares at $8.56; cluster of 4 insiders buying within 14 days; stock down -35.5% from 52-week high.

Director Haddock Richie Darrin purchased 5,780 shares at $8.56 on 2025-02-26, establishing a new position of 5,780 shares post-transaction. This buy signals insider appetite amid deteriorating price action: the stock has declined -35.5% from its 52-week high of $12.80 and fallen -27.4% over the past 30 days. The transaction is part of a broader cluster pattern, with 4 other insiders also buying within the past 14 days, suggesting coordinated conviction at a depressed valuation. However, context matters: the company posted a full-year net income of $-3,564,980.00 ($-3.6M) in its most recent fiscal year, indicating ongoing unprofitability. The cluster buy pattern coincides with significant losses from the 52-week peak and negative near-term momentum, warranting scrutiny of whether this insider accumulation reflects genuine operational recovery expectations or merely opportunistic accumulation at lower prices.

Director Robison Chris J buys 10,000 PPTA shares at $8.43; stock down 36.4% in 30 days, but insider has 100% 90-day win rate across 2 prior PPTA buys.

Director Robison Chris J purchased 10,000 shares at $8.43 on 2025-02-21, increasing his holdings by 16.7% to 70,000 shares. This buy occurs as PPTA trades 36.4% below its 30-day average and 37.3% below its 52-week high of $12.80, creating significant downside momentum. Notably, his prior two purchases at PPTA (2024-01-18 and 2023-09-05) were well-timed at the 90-day mark, posting returns of 108.1% and 1.6% respectively, with a 100% win rate across same-ticker history. The timing pattern and prior success suggest this director's buying activity at PPTA has been predictive of subsequent recovery, though the company reported negative net income of $-3.6M over its most recent full fiscal year. A cluster of 3 other insiders also buying within the past 14 days further reinforces insider accumulation at depressed prices.

Director Cole Andrew Phillip buys 9,450 shares of PPTA at $7.99; stock down 36.4% in 30 days amid cluster buying pattern

Cole Andrew Phillip, a Director, purchased 9,450 shares at $7.99 on 2025-02-24, representing an initiation of a position (from 0 to 9,450 shares). This transaction occurs within a cluster buy pattern—3 other insiders also bought within the past 14 days. The timing is notable: the stock has declined 36.4% over the past 30 days and trades 37.3% below its 52-week high of $12.80, currently at $8.03. The company is unprofitable, with net income of $-3.6M over its most recent full fiscal year. The coordinated insider buying activity into a sharp recent decline suggests board-level attention to valuation, though the company's negative earnings profile means this transaction occurs in a context of operational challenges.

Cherry Jonathan bought 1,160 shares of PPTA at $8.60 on 2025-02-21; stock down 37.3% from 52-week high; cluster of 3 other insiders buying within 14 days.

Cherry Jonathan purchased 1,160 shares at $8.60, committing $9,976.00 to a position with no prior holdings. The transaction occurs as the stock trades at $8.03, down -37.3% from its 52-week high of $12.80 and -36.4% over the past 30 days. Notably, this purchase is part of a cluster pattern: 3 other insiders also bought within the past 14 days. The company is unprofitable with a net income of -$3,564,980.00 over its most recent full fiscal year. The convergence of multiple insider purchases during a period of significant price decline, coupled with the company's negative earnings, warrants investor scrutiny of the underlying rationale for this coordinated activity.

Director Dean Robert Alan bought 5,000 shares of PPTA at $8.32; holdings doubled. Stock down 37.3% from 52-week high; company unprofitable. Cluster: 3 other insiders bought within 14 days.

Dean Robert Alan, a director, purchased 5,000 shares at $8.32, doubling his shareholding from 5,000 to 10,000 shares. This transaction occurs within a cluster pattern—3 other insiders also bought within the past 14 days—suggesting coordinated activity at the board or management level. The timing is notable given the stock's substantial decline: PPTA is down 37.3% from its 52-week high of $12.80 and has fallen 36.4% over the past 30 days, indicating the purchase was made into significant downward momentum. Against this backdrop, the company reported a net loss of $-3.6M in its most recent full fiscal year, presenting a combination of fundamental weakness and recent price deterioration. The concurrent buying by multiple insiders warrants attention to whether this represents opportunistic accumulation at depressed levels or signals management's assessment of underlying value amid operational challenges.